Besides reducing the burden of participation, sponsors benefit from lower costs and faster timelines. In addition, when patients are more engaged, patient protocol compliance increases.
https://www.pharmalive.com/wp-content/uploads/2022/10/Clinicaltrial-phone.jpg500750Administratorhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAdministrator2022-10-12 14:30:192023-02-15 09:19:58Q&A: Considerations sponsors should make when implementing BYOD strategies in decentralized/hybrid trials
